These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-005197-23 Funktionelle Ergebnisse der intravitrealen Injektion von Triamcinolonacetonid im Vergleich zur konventionellen Lasertherapie bei diabetischem Makulaödem. not-yet-due
Exempt Terminated 2005-002180-90 Lókoregionale Tiefenhyperthermie begleitend zu ACNU in der Rezidivtherapie von Patienten mit malignen Gliomen (WHO°III/IV)- Phase I/II-Studie 2008-04-01 not-yet-due
Completed, but no date, and reported results Terminated 2005-004851-37 Doppelblinde, randomisierte, prospektive multizentrische klinische Studie zur Definition der optimalen antibiotischen Therapiedauer bei Patienten mit unkomplizierter akuter Cholangitis: Moxifloxacin o... bad-data
Not reported 2005-005362-36 A PROSPECTIVE RANDOMISED, OPEN-LABELED, TRIAL COMPARING SIROLIMUS-CONTAINING VERSUS MTOR-INHIBITOR-FREE IMMUNOSUPPRESSION IN PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA 2014-03-03 due-trials
Reported results 2006-001375-38 Temozolomide and pegylated (PEG)-liposomal Doxorubicin in first line treatment of patients with Glioblastoma WHO Grad IV 2008-03-01 due-trials
Not reported 2007-002560-10 Multicentre pilot-study for the therapy of medulloblastoma of adults (NOA-07) 2018-10-12 due-trials
Reported results 2007-003561-40 A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function - PATRON-Study 2012-06-02 due-trials
Exempt 2007-004699-38 A prospective phase I/II, one-arm, multi-center, open label study of pioglitazone in combination with sorafenib and low dose IFN alpha in metastatic, non-resectable renal clear cell carcinoma 2009-11-24 not-yet-due
Completed, but no date, and reported results Terminated 2007-005548-25 Prospective, randomised (using minimisation), double-blind, placebo controlled study to evaluate the safety and efficacy of human normal immunoglobulin as a prophylactic agent against infections in pa... bad-data
Reported results 2009-009956-20 Prospective, randomized, controlled, mono-centric, two-armed, single-blinded pilot study for the treatment of venous and capillary vascular malformations by Indocyanine Green-augmented laser therapy 2011-04-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-012275-98 HEXVIX® VERUS WHITE LIGHT GUIDED TURB FOR EORTC SCORE INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER FOLLOWED BY ATTENUATED INTRAVESICAL ADJUVANT CHEMOTHERAPY. 2020-10-30 bad-data
Completed, but no date, and reported results 2009-014040-11 Multimodality treatment including pre- and postoperative systemic chemotherapy plus cetuximab, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with perito... bad-data
Not reported 2009-015383-33 Die perioperative Anwendung von Etoricoxib verglichen mit Diclofenac bei Patienten nach Implantation einer Hüftgelenkstotalendoprothese, prospektive, doppelt blinde Phase IIIb Studie 2014-04-08 due-trials
Ongoing 2009-016748-38 Prospective, randomized, placebo-controlled, monocentric, two-armed, observer-blinded and within-patient study for Photodynamic Therapy (PDT) with MAL in the treatment of actinic keratoses (AK) and ph... not-yet-due
Reported results 2009-017192-26 A 3-Armed Prospective Randomized Controlled, Open-Labeled Phase III Trial to Evaluate Late Introduction of Cyclosporine or Everolimus versus a 5-day Delay of Cyclosporine in Combination with MMF in Li... 2015-05-28 due-trials
Reported results 2010-019017-25 Efficacy of medical treatment with SOM230 LAR in patients with primary inoperable thymoma and/or with local recurrent thymoma to reduce tumor size 2015-10-30 due-trials
Completed, but no date, and reported results Terminated 2010-023575-25 Perioperative FOLFOXIRI and bevacizumab compared with postoperative FOLFOX in patients with resectable liver metastases from colorectal cancer (PERIMAX). bad-data
Completed, report not yet due 2011-004062-15 Prospective, open label, randomized phase II trial to assess a multimodal molecular targeted therapy in children, adolescent and young adults with relapsed or refractory high risk neuroblastoma Pro... 2022-04-16 not-yet-due
Reported results 2011-004301-24 The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation – Reference Group Trial 2015-12-29 due-trials
Exempt 2012-002685-12 Treatment of steroid resistant severe acute gastrointestinal graft-versus-host disease with in vitro expanded donor-derived regulatory T cells A prospective open-label one-armed non-randomized multice... not-yet-due
Exempt, with results Terminated 2013-000999-15 The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation - M reg Trial not-yet-due
Completed, but no date 2013-003370-27 Functional MRI (fMRI) after challenge and treatment with antidepressants and their relation to the clinical course, to the Hypothalamus-Hypophysis-Adrenocortical Axis and the colon microbiome Funkt... bad-data
Reported results 2014-004095-31 A prospective phase II, randomized multi-center trial of a combined modularized treatment with metronomic low-dose treosulfan, pioglitazone and clarithromycin versus nivolumab in patients with squamo... 2019-03-21 due-trials
Reported results 2014-005121-13 Prospective, randomized, controlled, multicenter, two-armed, study comparing daylight photodynamic therapy using MAL with cryosurgery for the treatment and prophylaxis of actinic keratoses in photodam... 2018-05-07 due-trials
Reported results 2015-004304-27 Prospective pilot trial to assess a multimodal molecular targeted therapy in children, adolescent and young adults with relapsed or refractory high-grade pineoblastoma 2021-04-30 due-trials
Reported results Terminated 2016-000421-39 Randomized Phase II trial with safety run-in phase evaluating low-dose azacitidine, all-trans retinoic acid and pioglitazone versus standard dose azacitidine in patients >=60 years with acute myeloid ... 2020-03-16 due-trials
Exempt 2016-003947-12 Treatment of steroid-resistant chronic graft-versus-host-disease with donor-derived regulatory T cells Therapie der Steroid-refraktären chronischen Graft-versus-Host-Erkrankung mit regulatorischen ... not-yet-due
Completed, but no date 2016-004730-18 The influence of Timolol Nasal Spray on Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Der Einfluss von Timolol Nasenspray auf Epistaxis bei Morbus Osler Patienten bad-data
No trial status on register 2018-002652-33 A phase 2 trial to assess haploidentical Alpha/ß T-depleted stem cell transplantation in patients with sickle cell disease with no available sibling donor bad-data
Ongoing 2020-000693-18 Breaking the big Five Barriers of Brain Metastasis (Break B5-BM NSCLC Trial): A prospective phase II, open-label, multi-center trial of combined nivolumab, ipilimumab and bevacizumab together with 2 c... not-yet-due
Ongoing 2020-000796-20 Multicentre, open-label, randomised, two-arm, parallel-group, superiority study to assess bioavailability and practicability of Envarsus® compared with Advagraf® in de novo liver transplant recipients... not-yet-due